Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1997-5-13
|
| pubmed:abstractText |
beta-tubulin, the intracellular target of several antimicrotubule agents, is encoded by at least six genes and exists as multiple isotypes with tissue-specific expression. Previous in vitro studies indicated that tubulin isotype composition may affect polymerization properties, dynamics, and sensitivity to drugs.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0270-4137
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
263-8
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9111604-Carcinoma,
pubmed-meshheading:9111604-Humans,
pubmed-meshheading:9111604-Immunohistochemistry,
pubmed-meshheading:9111604-Isomerism,
pubmed-meshheading:9111604-Male,
pubmed-meshheading:9111604-Prostatic Hyperplasia,
pubmed-meshheading:9111604-Prostatic Neoplasms,
pubmed-meshheading:9111604-Staining and Labeling,
pubmed-meshheading:9111604-Tubulin
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy.
|
| pubmed:affiliation |
Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|